Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 165 Enz. Inhib. hit(s) with all data for entry = 2999
TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316174(N-(3-((1H-benzo[d]imidazol-1-yl)methyl)-4-(4-methy...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM5655(2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydr...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In DepthDetails US Patent
DrugBank
MMDB
PDB3D3D Structure (crystal)

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316179(2-chloro-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316181(N-(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-yla...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316182((2-methoxy-5-(6-(2-methoxyphenyl) pyrimidin-4-ylam...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316188(N-(3-((1H-benzo[d]imidazol-1- yl)methyl)-4-chlorop...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316189((5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-(4-m...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316202(US10294218, Example 30 | US9617225, Example 30 | m...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316203(N-(3-((1H-benzo[d]imidazol-1- yl)methyl)-4-methoxy...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316204(2-methoxy-5-(6-(2- methoxyphenyl)pyrimidin-4- ylam...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316205(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316207(N-(3-((dimethylamino)methyl)-4-methoxyphenyl)-6-(2...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316209(N-(4-methoxy-3-((methylamino)methyl)phenyl)-6-(2-m...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316210(5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-(4-me...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316211(N-(3-((1H-benzo[d]imidazol-1-yl)methyl)-4-ethoxyph...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316212(N-(3-((1H-benzo[d]imidazol-1-yl)methyl)-4-fluoroph...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316217(2-methoxy-5-(6-(2- methoxyphenyl)pyrimidin-4- ylam...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316227(N-{2-Methoxy-5-[6-(2-methoxy-phenyl)-pyrimidin-4-y...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316285(2-Dimethylamino-5-[6-(4-fluoro-2-methoxy-phenyl)-p...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316288(US10294218, Example 116 | US9617225, Example 116 |...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316293(2-Methoxy-4-[6-(2-methoxy-phenyl)-pyrimidin-4-ylam...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316301(5-[6-(2-Ethoxy-phenyl)-pyrimidin-4- ylamino]-2-met...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316302(5-[6-(2-Ethoxy-4-fluoro-phenyl)- pyrimidin-4-ylami...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM7585((R,S)-Roscovitine | 2,6,9-Trisubstituted purine de...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316176(N-(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-yla...)
Affinity DataIC50: <100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316172(N-(3-((benzylamino)methyl)-4-methoxyphenyl)-6-(2-m...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316175(2-(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-yla...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316177(N1-(6-(2-methoxyphenyl)pyrimidin-4-yl)- N4,N4-dime...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316178((2-chloro-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316180(N-(4-methoxy-3-(2-morpholinoethoxy)phenyl)-6-(2-me...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316183(N-(4-methoxy-3-nitrophenyl)-6-(2-methoxyphenyl)pyr...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316184(4-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-nitro...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316185((2-methoxy-5-(6-(2-methoxyphenyl) pyrimidin-4-ylam...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316186(US10294218, Example 14 | US9617225, Example 14 | e...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316187((2-chloro-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316190(US10294218, Example 18 | US9617225, Example 18 | e...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316191((5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-morp...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316193(US10294218, Example 21 | US9617225, Example 21 | m...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316194(N-(3-fluoro-4-methoxyphenyl)-6-(2-methoxyphenyl)py...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316195(N-benzyl-2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316196((2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylami...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316197(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316200(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316201(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316213(4-methoxy-N1-(6-(2- methoxyphenyl)pyrimidin-4-yl) ...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316214(2-((1H-benzo[d]imidazol-1-yl(methyl)-N4-(6-(2-meth...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316215(N-(3-(aminomethyl)-4- methoxyphenyl)-6-(2- methoxy...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316216(2-chloro-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316218(2-Methoxy-5-[6-(2-methoxy-phenyl)-pyrimidin-4-ylam...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316219(2-Methoxy-5-[6-(2-methoxy-phenyl)-pyrimidin-4-ylam...)
Affinity DataIC50: <1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Displayed 1 to 50 (of 165 total ) | Next | Last >>
Jump to: